REG - Oncimmune Hldngs PLC - Director/PDMR's Dealing
RNS Number : 0419POncimmune Holdings PLC05 June 2020Oncimmune Holdings plc
("Oncimmune" or the "Company")
Director/PDMR's Dealing
Oncimmune Holdings plc (AIM: ONC.L), the leading global immunodiagnostics group, was informed that, on 4 June 2020, dealings in the Company's ordinary shares of £0.01 each in the Company ("Ordinary Shares") by the following Director / PDMRs had occurred:
- Meinhard Schmidt, Non-Executive Chairman, together with his wife and PCA, Tatiana Schmidt, acquired in aggregate 13,000 Ordinary Shares at a weighted average price of £1.885 per share
- Tim Bunting, Non-Executive Director, acquired 150,000 Ordinary Shares at a weighted average price of £1.192 per share
- Adam Hill, Chief Executive Officer, acquired 8,481 Ordinary Shares at a price of £1.179 per share
- Matthew Hall, Chief Financial Officer, acquired 1,272 Ordinary Shares at a price of £1.179 per share
- Ron Kirschner, General Counsel and Company Secretary, acquired 1,652 Ordinary Shares at a price of £1.204 per share
Director/PDMR/ PCA
No. of Ordinary Shares acquired
Resulting interest
Resulting % holding
Meinhard Schmidt / Tatiana Schmidt
13,000
31,000
0.05%
Tim Bunting
150,000
2,956,717
4.7%
Adam Hill
8,481
40,913
0.06%
Matthew Hall
1,272
11,935
0.02%
Ron Kirschner
1,652
1,652
0.003%
This announcement, including the notification below, is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Meinhard Schmidt / Tatiana Schmidt
2
Reason for the notification
a)
Position/status
Non-executive Chairman / PCA
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Oncimmune Holdings plc
b)
LEI
213800HCYIWT6YPI1I02
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of £0.01 each
Identification code
ISIN: GB00BYQ94H38
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s)
Price
Volume
£1.17
8,000
£1.21
5,000
d)
Aggregated information
- Aggregated volume
13,000 shares
Weighted average price of £1.885
- Price
e)
Date of the transaction
4 June 2020
f)
Place of the transaction
London stock exchange, AIM
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Timothy Bunting
2
Reason for the notification
a)
Position/status
Non-executive Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Oncimmune Holdings plc
b)
LEI
213800HCYIWT6YPI1I02
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of £0.01 each
Identification code
ISIN: GB00BYQ94H38
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s)
Price
Volume
£1.195
60,000
£1.19
90,000
d)
Aggregated information
- Aggregated volume
150,000 shares
Weighted average price of £1.192
- Price
e)
Date of the transaction
4 June 2020
f)
Place of the transaction
London stock exchange, AIM
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Dr Adam Mark Hill
2
Reason for the notification
a)
Position/status
Chief Executive Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Oncimmune Holdings plc
b)
LEI
213800HCYIWT6YPI1I02
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of £0.01 each
Identification code
ISIN: GB00BYQ94H38
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s)
Price
Volume
£1.179
8,481
d)
Aggregated information
- Aggregated volume
Same as above
- Price
e)
Date of the transaction
4 June 2020
f)
Place of the transaction
London stock exchange, AIM
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Matthew Hall
2
Reason for the notification
a)
Position/status
Chief Financial Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Oncimmune Holdings plc
b)
LEI
213800HCYIWT6YPI1I02
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of £0.01 each
Identification code
ISIN: GB00BYQ94H38
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s)
Price
Volume
£117.9
1,272
d)
Aggregated information
- Aggregated volume
Same as above
- Price
e)
Date of the transaction
4 June 2020
f)
Place of the transaction
London stock exchange, AIM
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Ron Kirschner
2
Reason for the notification
a)
Position/status
General Counsel and Company Secretary
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Oncimmune Holdings plc
b)
LEI
213800HCYIWT6YPI1I02
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of £0.01 each
Identification code
ISIN: GB00BYQ94H38
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s)
Price
Volume
£1.204
1,652
d)
Aggregated information
- Aggregated volume
Same as above
- Price
e)
Date of the transaction
4 June 2020
f)
Place of the transaction
London stock exchange, AIM
For further information:
Oncimmune Holdings plc
Ron Kirschner, General Counsel and Company Secretary
contact@oncimmune.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDDSHSSWESLESSEFM
Recent news on Oncimmune Holdings
See all newsREG - Oncimmune Hldgs PLC - Trading Update
AnnouncementREG - Oncimmune Hldgs PLC - Contract Win
AnnouncementREG - Oncimmune Hldgs PLC - US$1.5m Contract Win with Top 10 Pharma Company
AnnouncementREG - Oncimmune Hldgs PLC - Holding(s) in Company
AnnouncementREG - Oncimmune Hldgs PLC - Holding(s) in Company
Announcement